The $50 Weight-Loss Blueprint: Inside Medicare’s Unprecedented GLP-1 Pilot Program

Starting July 1, the Medicare GLP-1 Bridge pilot program will slash the cost of weight-loss drugs like Zepbound and Wegovy to a $50 monthly copay. Explore the eligibility criteria, financial caveats, and the program's 18-month timeline.